Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Antidotal Effects of Non-Specific Reversal Agents On Anticoagulant-Induced Inhibition of Thrombin Generation.

Daniele Pillitteri, Ann-Kathrin Pilgrimm-Thorp, Manuela Krause, Thomas Scholz, Rainer Schwerdtfeger, Tanja Behrendt, Carl Kirchmaier

Blood (2012) 120 (21): 2273.

https://doi.org/10.1182/blood.V120.21.2273.2273

Published: 2012

Journal Articles

Role of Inherited Bleeding Disorders in Women with Pregnancy Loss

Manuela Krause, Daniele Pillitteri, Ann-Kathrin Pilgrimm, Thomas Scholz, Rainer Schwerdtfeger, Carl Kirchmaier

Blood (2011) 118 (21): 4657.

https://doi.org/10.1182/blood.V118.21.4657.4657

Published: 2011

Journal Articles

Glanzmann Thrombasthenia - Novel Mutations In the Gpiib- and GPIIIa-Genes.

Daniele Pillitteri, Ann-Kathrin Pilgrimm, Thomas Scholz, Rainer Schwerdtfeger, MD, Manuela Krause, Carl Kirchmaier

Blood (2010) 116 (21): 3692.

https://doi.org/10.1182/blood.V116.21.3692.3692

Published: 2010

Journal Articles

Antidotal Effects of rFVIIa and FEIBA on Anticoagulant-Induced Inhibition of Thrombin Generation.

Daniele Pillitteri, MSc, Wolfgang Wegert, MSc, Thomas Scholz, Carl M. Kirchmaier, MD

Blood (2006) 108 (11): 4124.

https://doi.org/10.1182/blood.V108.11.4124.4124

Published: 2006

Journal Articles

rFVIIa Treatment and Efficacy Prediction in a Patient with Hermansky-Pudlak Syndrome Type 1 (HPS-1) Using Global Clotting Tests and Flow Cytometry.

Wolfgang Wegert, MSc, Thomas Scholz, Eng., Silke Ehrenforth, MD, Wolfgang Mondorf, MD, Carl M. Kirchmaier, MD

Blood (2005) 106 (11): 4019.

https://doi.org/10.1182/blood.V106.11.4019.4019

Published: 2005

Journal Articles

Factor VIII Efficacy and Tissue Factor Levels in Hemophilia A Patients Undergoing Total Knee Replacement.

Wolfgang Wegert, MS, Manuela Krause, MD, Inge Scharrer, MD, Ulla Stumpf, MD, Andreas Kurth, MD, Steffen Bassus, MD, PhD, Thomas Scholz, Eng., Carl M. Kirchmaier, MD

Blood (2004) 104 (11): 4029.

https://doi.org/10.1182/blood.V104.11.4029.4029

Published: 2004

Journal Articles

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests.

Steffen Bassus, MD, PhD, Wolfgang Wegert, MS, Manuela Krause, MD, Inge Scharrer, MD, Thomas Scholz, Eng., Carmen Escuriola-Ettinghausen, MD, Annelie Siegemund, MD, Wolfhart Kreuz, MD, Lothar Engelmann, MD, Carl M. Kirchmaier, MD

Blood (2004) 104 (11): 3098.

https://doi.org/10.1182/blood.V104.11.3098.3098

Published: 2004

NARROW

Antidotal Effects of Non-Specific Reversal Agents On Anticoagulant-Induced Inhibition of Thrombin Generation.

Role of Inherited Bleeding Disorders in Women with Pregnancy Loss

Glanzmann Thrombasthenia - Novel Mutations In the Gpiib- and GPIIIa-Genes.

Antidotal Effects of rFVIIa and FEIBA on Anticoagulant-Induced Inhibition of Thrombin Generation.

rFVIIa Treatment and Efficacy Prediction in a Patient with Hermansky-Pudlak Syndrome Type 1 (HPS-1) Using Global Clotting Tests and Flow Cytometry.

Factor VIII Efficacy and Tissue Factor Levels in Hemophilia A Patients Undergoing Total Knee Replacement.

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests.

Email alerts

ASH Publications

American Society of Hematology

Antidotal Effects of Non-Specific Reversal Agents On Anticoagulant-Induced Inhibition of Thrombin Generation.

Role of Inherited Bleeding Disorders in Women with Pregnancy Loss

Glanzmann Thrombasthenia - Novel Mutations In the Gpiib- and GPIIIa-Genes.

Antidotal Effects of rFVIIa and FEIBA on Anticoagulant-Induced Inhibition of Thrombin Generation.

rFVIIa Treatment and Efficacy Prediction in a Patient with Hermansky-Pudlak Syndrome Type 1 (HPS-1) Using Global Clotting Tests and Flow Cytometry.

Factor VIII Efficacy and Tissue Factor Levels in Hemophilia A Patients Undergoing Total Knee Replacement.

Monitoring of FVIII Replacement Therapy with Cell-Based Monitoring Tests.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only